The bill directs federal crop-insurance authorities to research and develop an insurance policy for mushroom farming and to deliver findings and recommendations to Congress. It focuses on whether and how the federal crop insurance system can cover losses tied to mushroom production or revenue.
This is significant because commercial mushroom production has different risk drivers than field crops (indoor cultivation, disease dynamics, short production cycles) and currently lacks widely available USDA-backed insurance products; a successful R&D effort could lead to new risk-management options for growers, lenders, and supply-chain partners.
At a Glance
What It Does
The bill amends 7 U.S.C. 1522(c) by adding subsection (20), instructing the Federal Crop Insurance Corporation (the Corporation) either to carry out research and development itself or to contract with qualified parties to study an insurance product for mushrooms. It also requires a written report with results and recommendations to specified Congressional committees.
Who It Affects
Commercial mushroom growers (including indoor and controlled-environment producers), crop-insurance program managers at the USDA, private actuarial firms and insurers who may be contracted, lenders that underwrite mushroom production, and specialty-crop supply chains that face production volatility.
Why It Matters
The bill opens a formal, federal pathway to evaluate insurance for a crop class that lacks standardized actuarial history. Its research mandate — not a direct authorization to insure — creates a structured process that could lead to pilot programs, new product development, or legislative recommendations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The statutory change is narrow but operationally consequential. It adds a new numbered item to the Federal Crop Insurance Act that makes the Federal Crop Insurance Corporation responsible for researching how an insurance product for mushrooms could work.
The Corporation can run that research in-house or hire outside experts under contract; the goal is to generate actionable analysis, not immediate coverage.
The research must examine insurance that protects either the physical production of mushrooms or the revenue growers derive from production. That phrasing keeps the options open between yield-style products (loss of output) and revenue-style products (price and yield combined), which invite different actuarial approaches, data needs, and delivery mechanisms.Within one year the Corporation must report to the House Agriculture Committee and the Senate Agriculture, Nutrition, and Forestry Committee with the research results and any recommendations.
The report will be the critical hinge: it should identify data gaps, cost estimates, product designs, pilot options, likely premium levels, and whether statutory or regulatory changes would be necessary to implement any recommended products.Practically, implementing the bill will require the Corporation to assemble production data, determine whether indoor/controlled-environment operations should be treated differently, design actuarial methods for short-cycle and high-density production systems, and weigh contracting approaches (e.g., academic, private actuarial services, industry consortia). The bill does not itself create an insurance program or commit funding, so the report will likely be the first step toward pilots or rulemaking if Congress or USDA decide to move forward.
The Five Things You Need to Know
The bill inserts a new subsection (20) titled “MUSHROOMS” into 7 U.S.C. 1522(c), the statutory authority for the Federal Crop Insurance Corporation.
It requires the Corporation to either carry out research and development itself or enter into one or more contracts with qualified persons to carry out that work.
The research must address insurance of either the production of mushrooms or the revenue derived from mushroom production — explicitly allowing yield-style or revenue-style approaches.
The Corporation must submit a report describing results and recommendations to the House Agriculture Committee and the Senate Agriculture, Nutrition, and Forestry Committee no later than one year after enactment.
The text contains no express appropriation or subsidy language; the bill mandates research and a report but does not authorize funds or immediate insurance coverage.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Declares the Act’s short title as the “Protecting Mushroom Farmers Act.” This is purely formal but signals the bill’s targeted policy focus to readers and to administrative implementers.
Adds a mushroom-specific research mandate
Adds a new numbered paragraph to the Federal Crop Insurance Act directing the Federal Crop Insurance Corporation to study insurance options for mushrooms. The placement inside section 522(c) ties the task to the Corporation’s existing research and development remit, which covers developing new products and pilot programs for specialty and emerging crops.
Corporation to perform or contract R&D
Gives the Corporation the choice to perform research internally or to contract with one or more qualified persons. That dual path allows flexibility: the agency can leverage in-house actuarial staff or fast-track external experts (universities, private actuaries, industry groups). The provision does not define “qualified persons,” leaving the selection standards and procurement approach for administrative rules or internal policy.
One-year report to Congressional agriculture committees
Requires a report within one year to the House and Senate agriculture committees describing the research results and any recommendations. The report deadline creates a compact timeline for data collection and analysis. Because the bill requires recommendations, the report will likely address next steps such as pilots, necessary statutory changes, potential premium and subsidy estimates, and implementation risks.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Commercial mushroom growers — gain a formal federal study that could lead to new insured options tailored to indoor and specialty production risks, improving bankability and risk management.
- Lenders and input suppliers — would obtain clearer risk metrics and possibly federally backed insurance products that reduce credit risk for mushroom operations.
- Private actuarial firms and specialty-crop consultants — stand to win contracts to develop actuarial tables, pilot designs, or underwriting frameworks under the Corporation’s contracting option.
- Vertical farms and controlled-environment agriculture firms — would get a concrete assessment of whether federal insurance can be adapted to indoor production, which currently falls into a gray area for many crop-insurance products.
Who Bears the Cost
- Federal Crop Insurance Corporation / USDA operations — must allocate staff time and existing program resources to design and manage research or contracting processes, potentially displacing other product development work.
- Taxpayers — while the bill does not appropriate funds, any later decision to pilot or subsidize a mushroom insurance product could require new appropriations or shift program funds toward actuarial development and subsidies.
- Private insurers and reinsurers — may face new actuarial and underwriting requirements if a federal product is developed; they may also compete for contracts without guaranteed long-term business.
- Growers — could face new premium costs if a federal product is implemented without subsidy; product design choices (e.g., high deductible or limited coverage) could leave some producers underinsured despite availability.
Key Issues
The Core Tension
The bill pits two legitimate goals against each other: expand federal risk-management tools to a growing, underserved specialty-crop sector versus the practical limits of actuarial data, program budgets, and administrative capacity. Research can reveal feasible, affordable products, but it may also show that viable coverage requires subsidies or statutory changes that raise budgetary and policy trade-offs.
The bill is narrow and procedural: it orders research, not insurance. That limits immediate effects but places heavy weight on the Corporation’s forthcoming report.
A central implementation challenge is data scarcity: many mushroom operations are small, vertically integrated, or indoors, and historical loss records suitable for traditional crop-insurance rate-setting may be thin or inconsistent. Designing actuarial methods that credibly price risk without producing unaffordable premiums or exposing the program to adverse selection will be difficult.
Several definitional and scope questions are unresolved in the text. The bill does not define “mushrooms,” which raises questions about cultivated varieties versus wild-harvested mushrooms or fungiculture for non-food uses.
It also leaves “qualified persons” undefined, creating procurement and conflict-of-interest choices for the Corporation. Finally, because the bill does not appropriate funds, the Corporation must choose between reallocating current resources, seeking USDA support, or running limited-scope contracts — each option affects the depth and impartiality of the research.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.